Gyeonggi, South Korea

Jong-Woo Park

This inventor holds 1 USPTO granted patent. Top assignee: Choongwae Pharma Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong-Woo Park. Retrieved from https://idiyas.com/inventor/jong-woo-park-ful02llv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jong-Woo Park: Innovator in Antifungal Drug Preparation

Introduction

Jong-Woo Park is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral preparations for antifungal drugs. His innovative approach has led to advancements in drug bioavailability, which is crucial for effective treatment.

Latest Patents

Jong-Woo Park holds 1 patent for his invention titled "Method and composition of an oral preparation of itraconazole." This invention relates to an improved method of preparing itraconazole, an effective azole antifungal drug. The process involves dissolving itraconazole and a hydrophilic polymer in a solvent, followed by spray-drying the mixture to create solid dispersions. These solid dispersions can be utilized in the formulation of tablets, granules, and other oral dosage forms, enhancing the drug's bioavailability.

Career Highlights

Jong-Woo Park is associated with Choongwae Pharma Corporation, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry. His work not only contributes to the advancement of antifungal treatments but also reflects his commitment to improving patient outcomes.

Collaborations

Jong-Woo Park collaborates with talented professionals in his field, including Jae-Young Jung and Kye-Hyun Kim. These collaborations foster a creative environment that encourages the development of groundbreaking pharmaceutical innovations.

Conclusion

Jong-Woo Park's contributions to the pharmaceutical industry, particularly in the formulation of itraconazole, highlight his role as an innovator. His work exemplifies the importance of improving drug bioavailability for better therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…